{
    "2020-04-24": [
        [
            {
                "time": "2019-12-31",
                "original_text": "智飞生物：2019年营收同比增长102.50%，拟10股派5元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "营收增长",
                        "派息"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "[路演]智飞生物：HPV疫苗相关采购协议正常履行中",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "HPV疫苗",
                        "采购协议"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-16",
                "original_text": "[路演]智飞生物：重组结核杆菌融合蛋白正在上市生产审评之中",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组结核杆菌融合蛋白",
                        "审评"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-17",
                "original_text": "[路演]智飞生物：新冠疫苗目前正处于临床前研究阶段",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "临床前研究"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-18",
                "original_text": "【东北医药崔洁铭/马千里】智飞生物（300122）年报点评：代理产品持续放量，公司业绩符合预期",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "代理产品",
                        "业绩符合预期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}